You are currently viewing a new version of our website. To view the old version click .

Vaccination and Public Health

Special Issue Information

Dear Colleagues,

Now more than ever, vaccines are the central focus of public health efforts to control a pandemic while maintaining routine immunization efforts. Vaccine-preventable disease continue to cause significant morbidity, mortality and economic burden around the world.  Strategies for rolling out vaccination programs, improving routine immunization rates, and increasing vaccine acceptance are in constant need of research and optimization during both pandemic and non-pandemic times.

We are pleased to invite you to submit an article to this Special Issue on Vaccination and Public Health. Research areas may include (but are not limited to) the following: (1) vaccination strategies and herd immunity; (2) vaccination of special populations including those with impaired immunity, pregnant women, breastfeeding women, and children;  (3) vaccine safety assessment; (4) vaccines cost effectiveness and impact studies;  (5) assessment and interventions to promote vaccine acceptance; (6) strategies to improve vaccine access and equality; and (7) novel vaccine platforms.  The Special Issue will include studies on both COVID-19, routine vaccinations and experimental vaccines and vaccine preventable diseases. Original research articles and reviews are welcome.

We look forward to receiving your contributions. 

Prof. Dr. Pia S. Pannaraj
Prof. Dr. Kirsty Le Doare
Prof. Dr. Norberto Giglio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccines
  • vaccine-preventable diseases
  • public health
  • herd immunity
  • vaccination strategy
  • cost-effectiveness
  • vaccine safety

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393XCreative Common CC BY license